NCT04959903
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
Clinical trial condition
Hematological Malignancies
Explore clinical trials studying Hematological Malignancies. Study availability and eligibility vary by location and protocol.
102 public trials
22 recruiting studies
Hematological Malignancies trial results
NCT01821456
- Conditions
- Agranulocytosis, Cancer, Chemotherapy, +11 more
- Locations
-
- University Hospital of Cologne Cologne, North Rhine-Westphalia, Germany
Not yet recruiting
A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies
NCT07809139
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- Jiangxi Cancer Hospital Nanchang, Jiangxi, China
NCT07809126
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT07137481
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Not yet recruiting
mNGS for IFD in Patients With Hematological Malignancies
NCT07763184
- Conditions
- Bacterial Infections and Mycoses, Hematologic Diseases, Hematologic Neoplasms, +8 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Not yet recruiting
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
NCT07621289
- Conditions
- Anticancer Treatment, Cancer, Cardiovascular Disease Risk Factor, +7 more
- Locations
-
Not specified
Not yet recruiting
Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors
NCT06992934
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
- Locations
-
- CHU de NICE Nice, France
Not yet recruiting
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
NCT07636486
- Conditions
- Epoetin, Hematologic Diseases, Hematologic Neoplasms, +6 more
- Locations
-
- Department of Hematology, Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Not yet recruiting
Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies
NCT07635511
- Conditions
- HLA Antibodies, Hematologic Diseases, Hematologic Neoplasms, +5 more
- Locations
-
Not specified